Advances in Pathogenesis and Treatment of Vascular Endothelial Injury-related Diseases Mediated by Mitochondrial Abnormality

Overview

Journal Front Pharmacol

Date 2024 Sep 16

PMID 39281286

Authors

Boxian Pang

Guangtong Dong

Tieliang Pang

Xinyao Sun

Xin Liu

Yifeng Nie

Xing Chang

Affiliations

Soon will be listed here.

Abstract

Vascular endothelial cells, serving as a barrier between blood and the arterial wall, play a crucial role in the early stages of the development of atherosclerosis, cardiovascular diseases (CVDs), and Alzheimer's disease (AD). Mitochondria, known as the powerhouses of the cell, are not only involved in energy production but also regulate key biological processes in vascular endothelial cells, including redox signaling, cellular aging, calcium homeostasis, angiogenesis, apoptosis, and inflammatory responses. The mitochondrial quality control (MQC) system is essential for maintaining mitochondrial homeostasis. Current research indicates that mitochondrial dysfunction is a significant driver of endothelial injury and CVDs. This article provides a comprehensive overview of the causes of endothelial injury in CVDs, ischemic stroke in cerebrovascular diseases, and AD, elucidating the roles and mechanisms of mitochondria in these conditions, and aims to develop more effective therapeutic strategies. Additionally, the article offers treatment strategies for cardiovascular and cerebrovascular diseases, including the use of clinical drugs, antioxidants, stem cell therapy, and specific polyphenols, providing new insights and methods for the clinical diagnosis and treatment of related vascular injuries to improve patient prognosis and quality of life. Future research should delve deeper into the molecular and mechanistic links between mitochondrial abnormalities and endothelial injury, and explore how to regulate mitochondrial function to prevent and treat CVDs.

References

Liao J, Chen G, Liu X, Wei Z, Yu S, Chen Q . C/EBPβ/AEP signaling couples atherosclerosis to the pathogenesis of Alzheimer's disease. Mol Psychiatry. 2022; 27(7):3034-3046. PMC: 9912845. DOI: 10.1038/s41380-022-01556-0. View

Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, Yano M . Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes. 2005; 55(1):120-7. View

Chen C, Hsu P, Wang T, Miao Z, Lin R, Juo S . TRPV4 Activation Contributes Functional Recovery from Ischemic Stroke via Angiogenesis and Neurogenesis. Mol Neurobiol. 2017; 55(5):4127-4135. DOI: 10.1007/s12035-017-0625-0. View

Zhou H, He Y, Zhu J, Lin X, Chen J, Shao C . Guhong Injection Protects Against Apoptosis in Cerebral Ischemia by Maintaining Cerebral Microvasculature and Mitochondrial Integrity Through the PI3K/AKT Pathway. Front Pharmacol. 2021; 12:650983. PMC: 8155598. DOI: 10.3389/fphar.2021.650983. View

Chen Y, Li S, Yin M, Li Y, Chen C, Zhang J . Isorhapontigenin Attenuates Cardiac Microvascular Injury in Diabetes via the Inhibition of Mitochondria-Associated Ferroptosis Through PRDX2-MFN2-ACSL4 Pathways. Diabetes. 2022; 72(3):389-404. DOI: 10.2337/db22-0553. View

Gan Z, Fu T, Kelly D, Vega R . Skeletal muscle mitochondrial remodeling in exercise and diseases. Cell Res. 2018; 28(10):969-980. PMC: 6170448. DOI: 10.1038/s41422-018-0078-7. View

Dave K, Stolz D, Venna V, Quaicoe V, Maniskas M, Reynolds M . Mitochondria-containing extracellular vesicles (EV) reduce mouse brain infarct sizes and EV/HSP27 protect ischemic brain endothelial cultures. J Control Release. 2023; 354:368-393. PMC: 9974867. DOI: 10.1016/j.jconrel.2023.01.025. View

Wang H, Ramshekar A, Kunz E, Sacks D, Hartnett M . IQGAP1 causes choroidal neovascularization by sustaining VEGFR2-mediated Rac1 activation. Angiogenesis. 2020; 23(4):685-698. PMC: 7530064. DOI: 10.1007/s10456-020-09740-y. View

Muntean D, Sturza A, Danila M, Borza C, Duicu O, Mornos C . The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies. Oxid Med Cell Longev. 2016; 2016:8254942. PMC: 4856919. DOI: 10.1155/2016/8254942. View

10.

Aliev G, Palacios H, Walrafen B, Lipsitt A, Obrenovich M, Morales L . Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Int J Biochem Cell Biol. 2009; 41(10):1989-2004. DOI: 10.1016/j.biocel.2009.03.015. View

11.

Wang J, Toan S, Zhou H . New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis. 2020; 23(3):299-314. DOI: 10.1007/s10456-020-09720-2. View

12.

Guo J, Krause D, Horne J, Weiss J, Li X, Duckles S . Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. J Cereb Blood Flow Metab. 2009; 30(3):545-54. PMC: 2831126. DOI: 10.1038/jcbfm.2009.226. View

13.

Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto J, Bagi Z, Ballabh P . Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol. 2009; 297(5):H1876-81. PMC: 2781360. DOI: 10.1152/ajpheart.00375.2009. View

14.

Huang L, Reis C, Boling W, Zhang J . Stem Cell Therapy in Brain Ischemia: The Role of Mitochondrial Transfer. Stem Cells Dev. 2020; 29(9):555-561. DOI: 10.1089/scd.2019.0237. View

15.

Liu X, Chu B, Jin S, Li M, Xu Y, Yang H . Vascular endothelial growth factor alleviates mitochondrial dysfunction and suppression of mitochondrial biogenesis in models of Alzheimer's disease. Int J Neurosci. 2020; 131(2):154-162. DOI: 10.1080/00207454.2020.1733564. View

16.

Parodi-Rullan R, Sone J, Fossati S . Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease. J Alzheimers Dis. 2019; 72(4):1019-1039. PMC: 6917858. DOI: 10.3233/JAD-190357. View

17.

Iadecola C . The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010; 120(3):287-96. PMC: 3001188. DOI: 10.1007/s00401-010-0718-6. View

18.

DSouza A, Burch A, Dave K, Sreeram A, Reynolds M, Dobbins D . Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells. J Control Release. 2021; 338:505-526. PMC: 8526414. DOI: 10.1016/j.jconrel.2021.08.038. View

19.

Murphy M, Smith R . Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev. 2000; 41(2):235-50. DOI: 10.1016/s0169-409x(99)00069-1. View

20.

Lyros E, Bakogiannis C, Liu Y, Fassbender K . Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease. Curr Alzheimer Res. 2013; 11(1):18-26. DOI: 10.2174/1567205010666131119235254. View